Protalix BioTherapeutics set to join Russell 3000® Inde

/PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization...

Related Keywords

United States , Carmiel , Ha Afon , Israel , Brazil , London , City Of , United Kingdom , American , Chuck Padala , Chiesi Farmaceutici , Dror Bashan , Pfizer Inc , Prnewswire Protalix Biotherapeutics Inc , Protalix Biotherapeutics Inc , European Union , European Medicines Agency , Drug Administration , Exchange Commission , London Stock Exchange Group , Chief Executive , London Stock Exchange , Private Securities Litigation Reform Act , Protalix Biotherapeutics , Nc ,